The Chemours Company Stock Price and Value Analysis

Should you buy The Chemours Company stock? (NYSE:CC). Let's see how it does in our automated value investing analysis system.

  • This company has a large dividend yield!
  • This company has wild ups and downs.
  • This company is not making money.
  • This stock looks overpriced.
  • This company is less known than others.

Inside the CC Numbers

CC Price
(The Chemours Company stock price per share)
[?] PE Ratio versus Sector 76% higher than other Basic Materials stocks
[?] PE Ratio versus Industry 0% lower than other Specialty Chemicals stocks
[?] Free Cash Flow Jitter 259%
[?] Dividend Yield 3%
Shares Shorted 5,223,437

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 5,223,437 shares shorted. With 149,040,288 shares available for purchase and an average trading volume over the past 10 trading days of 1,130,050, it would take at least 4.622 days for all of the short holders to cover their shorts.

Is The Chemours Company Stock on Sale?

Based on our analysis, we believe that you should not buy The Chemours Company right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy CC Stock?

Does The Chemours Company have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.